Trimethylamine N-oxide as a potential prognostic biomarker for mortality in patients with COVID-19 disease
- 5 February 2025
- journal article
- Published by Elsevier in Advances in Medical Sciences
- Vol. 70 (1) , 174-183
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- A metabolic readout of the urine metabolome of COVID-19 patientsMetabolomics, 2023
- Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infectionInflammation Research, 2021
- Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysisThe American Journal of Emergency Medicine, 2021
- Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?European Journal of Nutrition, 2021
- Anemia and iron metabolism in COVID-19: a systematic review and meta-analysisEuropean Journal of Epidemiology, 2020
- COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapyImmunologic Research, 2020
- Choice of y-axis can mislead readersNaunyn-Schmiedeberg's Archives of Pharmacology, 2020
- Neutrophil‐to‐lymphocyte ratio and lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): A meta‐analysisJournal of Medical Virology, 2020
- Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysisThe American Journal of Emergency Medicine, 2020
- Plasma trimethylamine‐N‐oxide following supplementation with vitamin D or D plus B vitaminsMolecular Nutrition & Food Research, 2016